Competing Endogenous TMPO-AS1-let-7c-5p- LDHA RNA Network Predicts the Prognosis of Lung Adenocarcinoma Patients

Overview

Journal Asian Pac J Cancer Prev

Specialty Oncology

Date 2024 Oct 29

PMID 39471036

Authors

Rajeev Nema

Prerna Vats

Jai Singh

Sandeep K Srivastava

Ashok Kumar

Affiliations

Soon will be listed here.

Abstract

Objective: Lactate dehydrogenase is dysregulated in several cancer types. However, the mechanism of its dysregulation in lung cancer is not fully understood. We utilized web-based computational databases to conduct gene expression analysis on LDHA, identified its regulator, and explored their role in the prognosis of lung cancer.

Methods: We used various web-based computational tools, including the UALCAN, TIMER2.0, ENCORI, TCGA Portal, OncoDB, and GEPIA2 datasets for lung cancer analysis in this study. We also performed survival, biological processes, and metastasis analysis using various computational tools. We also carried out co-expression functional enrichment analysis using the Enrichr and TIMER databases, multivariate analysis of survival and pathological stage, and transcriptional regulation analysis using the ENCORI and OncoDB datasets. Furthermore, LDHA inhibitor binding of withanolides was analyzed using Auto Dock Tools 1.5.6, LigPlot+, and Pymol.

Results: The study found that the higher levels of LDHA gene expression were associated with poor prognosis and overall survival in lung cancer patients. We identified 11 key genes co-expressed with LDHA; out of them, two genes, MKI67 and PGK1, showed a strong positive correlation with LDHA and associated poor survival outcomes in LUAD patients. Furthermore, we also identified hsa-let-7c-5p and TMPO-AS1 as potential regulators of LDHA in LUAD. It might be possible that the TMPO-AS1- hsa-let-7c-5p-LDHA ceRNA network could serve as a potential regulator of aerobic glycolysis in LUAD and can serve as prognostic biomarkers. Further, Withanolides can inhibit the activity of LDHA and can be tested as an adjuvant treatment.

Conclusion: We conclude that LDHA is overexpressed in LUAD, and the patients with high expression of LDHA exhibit poor prognosis. Further, the TMPO-AS1-hsa-let-7c-5p-LDHA ceRNA network can regulate aerobic glycolysis, thereby facilitating tumor growth in lung cancer.

Citing Articles

LUCAT1-Mediated Competing Endogenous RNA (ceRNA) Network in Triple-Negative Breast Cancer.

Verma D, Siddharth S, Yende A, Wu Q, Sharma D Cells. 2024; 13(22).

PMID: 39594666 PMC: 11593075. DOI: 10.3390/cells13221918.

References

Wang W, Liu H, Li G . What's the difference between lung adenocarcinoma and lung squamous cell carcinoma? Evidence from a retrospective analysis in a cohort of Chinese patients. Front Endocrinol (Lausanne). 2022; 13:947443. PMC: 9465444. DOI: 10.3389/fendo.2022.947443. View

Mishra D, Banerjee D . Lactate Dehydrogenases as Metabolic Links between Tumor and Stroma in the Tumor Microenvironment. Cancers (Basel). 2019; 11(6). PMC: 6627402. DOI: 10.3390/cancers11060750. View

Tang G, Cho M, Wang X . OncoDB: an interactive online database for analysis of gene expression and viral infection in cancer. Nucleic Acids Res. 2021; 50(D1):D1334-D1339. PMC: 8728272. DOI: 10.1093/nar/gkab970. View

Shiratori R, Furuichi K, Yamaguchi M, Miyazaki N, Aoki H, Chibana H . Glycolytic suppression dramatically changes the intracellular metabolic profile of multiple cancer cell lines in a mitochondrial metabolism-dependent manner. Sci Rep. 2019; 9(1):18699. PMC: 6904735. DOI: 10.1038/s41598-019-55296-3. View

de Visser K, Joyce J . The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth. Cancer Cell. 2023; 41(3):374-403. DOI: 10.1016/j.ccell.2023.02.016. View

Feng Y, Xiong Y, Qiao T, Li X, Jia L, Han Y . Lactate dehydrogenase A: A key player in carcinogenesis and potential target in cancer therapy. Cancer Med. 2018; 7(12):6124-6136. PMC: 6308051. DOI: 10.1002/cam4.1820. View

Kuleshov M, Jones M, Rouillard A, Fernandez N, Duan Q, Wang Z . Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 2016; 44(W1):W90-7. PMC: 4987924. DOI: 10.1093/nar/gkw377. View

Zhao H, Yin X, Xu H, Liu K, Liu W, Wang L . LncTarD 2.0: an updated comprehensive database for experimentally-supported functional lncRNA-target regulations in human diseases. Nucleic Acids Res. 2022; 51(D1):D199-D207. PMC: 9825480. DOI: 10.1093/nar/gkac984. View

Sharma R . Mapping of global, regional and national incidence, mortality and mortality-to-incidence ratio of lung cancer in 2020 and 2050. Int J Clin Oncol. 2022; 27(4):665-675. PMC: 8753949. DOI: 10.1007/s10147-021-02108-2. View

10.

Zhao L, Wu X, Li T, Luo J, Dong D . ctcRbase: the gene expression database of circulating tumor cells and microemboli. Database (Oxford). 2020; 2020. PMC: 7158883. DOI: 10.1093/database/baaa020. View

11.

Gan Z, Abudurexiti A, Hu X, Chen W, Zhang N, Sang W . E2F3/5/8 serve as potential prognostic biomarkers and new therapeutic direction for human bladder cancer. Medicine (Baltimore). 2024; 103(2):e35722. PMC: 10783276. DOI: 10.1097/MD.0000000000035722. View

12.

Lampe K, Namba R, Silverman T, Bjugstad K, Mahoney M . Impact of lactic acid on cell proliferation and free radical-induced cell death in monolayer cultures of neural precursor cells. Biotechnol Bioeng. 2009; 103(6):1214-23. PMC: 2748734. DOI: 10.1002/bit.22352. View

13.

Liu C, Hu F, Xie G, Miao Y, Li X, Zeng Y . GSCA: an integrated platform for gene set cancer analysis at genomic, pharmacogenomic and immunogenomic levels. Brief Bioinform. 2022; 24(1). DOI: 10.1093/bib/bbac558. View

14.

Pettersen E, Goddard T, Huang C, Couch G, Greenblatt D, Meng E . UCSF Chimera--a visualization system for exploratory research and analysis. J Comput Chem. 2004; 25(13):1605-12. DOI: 10.1002/jcc.20084. View

15.

Kim S, Chen J, Cheng T, Gindulyte A, He J, He S . PubChem 2023 update. Nucleic Acids Res. 2022; 51(D1):D1373-D1380. PMC: 9825602. DOI: 10.1093/nar/gkac956. View

16.

Uhlen M, Oksvold P, Fagerberg L, Lundberg E, Jonasson K, Forsberg M . Towards a knowledge-based Human Protein Atlas. Nat Biotechnol. 2010; 28(12):1248-50. DOI: 10.1038/nbt1210-1248. View

17.

Gyorffy B . Transcriptome-level discovery of survival-associated biomarkers and therapy targets in non-small-cell lung cancer. Br J Pharmacol. 2023; 181(3):362-374. DOI: 10.1111/bph.16257. View

18.

Yuan H, Yan M, Zhang G, Liu W, Deng C, Liao G . CancerSEA: a cancer single-cell state atlas. Nucleic Acids Res. 2018; 47(D1):D900-D908. PMC: 6324047. DOI: 10.1093/nar/gky939. View

19.

Stine Z, Schug Z, Salvino J, Dang C . Targeting cancer metabolism in the era of precision oncology. Nat Rev Drug Discov. 2021; 21(2):141-162. PMC: 8641543. DOI: 10.1038/s41573-021-00339-6. View

20.

Menon A, Abd-Aziz N, Khalid K, Poh C, Naidu R . miRNA: A Promising Therapeutic Target in Cancer. Int J Mol Sci. 2022; 23(19). PMC: 9569513. DOI: 10.3390/ijms231911502. View